Full details, including potential risk factors, are given in the Press Release, which can be consulted by clicking on the link below
Aqueous Humor Dynamics Of NCX 470 Ophthalmic Solution (Nitric Oxide-Donating Bimatoprost): A Double-Masked, Placebo-Controlled, Phase 3b Clinical Trial

February 24, 2026

View Press Release Corporate presentation Contact us
Previous